# Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer

> **NCT00003124** · PHASE2 · COMPLETED · sponsor: **Herbert Irving Comprehensive Cancer Center** · enrollment: 105 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** flutamide
- **DRUG:** leuprolide acetate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003124
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-05
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2014-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003124, "Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00003124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*